Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Gusev

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
NPJ Precision Oncology|November 1, 2022
Prediction of early-stage melanoma recurrence using clinical and histopathologic featuresGuihong Wan, Nga Nguyen, Feng Liu, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Cancers modulate p53 truncal neoantigen display to evade T cell detectionKoji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
An agentic AI system enhances clinical detection of immunotherapy toxicities: a multi-phase validation studyJack Gallifant, Shan Chen, Kee-Young Shin, et al.
Human Molecular Genetics|May 21, 2014
Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypesVladimir Vacic, Laurie J Ozelius, Lorraine N Clark, et al.
Genome Medicine|January 19, 2022
Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1Restuadi Restuadi, Frederik J Steyn, Edor Kabashi, et al.
American Journal of Human Genetics|October 3, 2015
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk ScoresBjarni J Vilhjálmsson, Jian Yang, Hilary K Finucane, et al.
Journal of the American Academy of Dermatology|February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapyNga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Science Advances|November 24, 2021
Predicting master transcription factors from pan-cancer expression dataJessica Reddy, Marcos A S Fonseca, Rosario I Corona, et al.
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Nature|February 25, 2026
Functional dissection of complex trait variants at single-nucleotide resolutionLayla Siraj, Rodrigo I Castro, Hannah B Dewey, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
NPJ Precision Oncology|November 1, 2022
Prediction of early-stage melanoma recurrence using clinical and histopathologic featuresGuihong Wan, Nga Nguyen, Feng Liu, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Cancers modulate p53 truncal neoantigen display to evade T cell detectionKoji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
An agentic AI system enhances clinical detection of immunotherapy toxicities: a multi-phase validation studyJack Gallifant, Shan Chen, Kee-Young Shin, et al.
Human Molecular Genetics|May 21, 2014
Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypesVladimir Vacic, Laurie J Ozelius, Lorraine N Clark, et al.
Genome Medicine|January 19, 2022
Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1Restuadi Restuadi, Frederik J Steyn, Edor Kabashi, et al.
American Journal of Human Genetics|October 3, 2015
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk ScoresBjarni J Vilhjálmsson, Jian Yang, Hilary K Finucane, et al.
Journal of the American Academy of Dermatology|February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapyNga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Science Advances|November 24, 2021
Predicting master transcription factors from pan-cancer expression dataJessica Reddy, Marcos A S Fonseca, Rosario I Corona, et al.
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Nature|February 25, 2026
Functional dissection of complex trait variants at single-nucleotide resolutionLayla Siraj, Rodrigo I Castro, Hannah B Dewey, et al.
Pageof 18